Sachin S Chandran

Title: The Innovative Contributions of Sachin S Chandran

Introduction

Sachin S Chandran is a notable inventor based in Highland Park, NJ (US). He has made significant contributions to the field of cancer therapy, particularly through his innovative work on nanoparticles. With a total of 3 patents, his inventions are paving the way for advancements in targeted cancer treatments.

Latest Patents

One of his latest patents focuses on prostate-specific membrane antigen (PSMA) targeted nanoparticles for the therapy of prostate cancer. This invention provides a nanoparticle composition that is decorated with a urea-based small-molecule peptidomimetic inhibitor of PSMA, which is expressed by almost all solid tumors. The strategy takes advantage of both the avidity of the functionalized nanoparticle for binding to PSMA and the ability of the nanoparticle to be retained for longer periods of time in the tumor. This retention is due to enhanced leakage via enhanced permeability and retention (EPR) into the tumor interstitium and poor clearance due to underdeveloped or non-existent lymphatics within the tumor.

Career Highlights

Throughout his career, Sachin has worked with prestigious organizations such as Johns Hopkins University and Bristol-Myers Squibb Company. His experience in these institutions has contributed to his expertise in the field of biomedical research and innovation.

Collaborations

Sachin has collaborated with notable colleagues, including Sangeeta Ray and Martin Gilbert Pomper. These partnerships have further enriched his research and development efforts in cancer therapies.

Conclusion

Sachin S Chandran's work exemplifies the impact of innovative thinking in the medical field. His contributions to cancer therapy through nanoparticle technology are significant and hold promise for future advancements in treatment options.